Kah Min Yap
@kahmin98
Dedicating my first post on X to share some exciting news — our work is out today in @Nature! 🎉 Co-first authored with the amazing lab buddy @_amandachen, and guided by our incredible supervisors @paulbeavis4, Phil & @ImranHouse. nature.com/articles/s4158…
Nature research paper: Rewiring endogenous genes in CAR T cells for tumour-restricted payload delivery go.nature.com/4le7GMB
Pleased to present the latest work from the lab published in @NatureComms in work led by @kevin_sek: nature.com/articles/s4146…
NR4A2 & RGS16 promoters support delivery of cytokines (e.g. IL-12) directly to the tumor site, leading to enhanced antitumor efficacy and long-term survival of mice in both syngeneic and xenogeneic models @Nature @paulbeavis4 @_amandachen @emsderrick nature.com/articles/s4158…
CAR T cells are engineered to drive tumor-restricted expression of proinflammatory cytokines by repurposing endogenous gene regulatory mechanisms nature.com/articles/s4158… #NBThighlight
Happy to share a new study led by all-star team @_amandachen, @kahmin98, @ImranHouse, Phil Darcy and @paulbeavis4 showing that tumor site-specific delivery of potent cytokines is a safe way to boost CAR T cell treatment against solid cancers! nature.com/articles/s4158…
Delighted to share our new approach to enhance CAR T cell function in solid tumours published today @Nature. In this work we identify a new strategy to generate armoured CAR T cells. nature.com/articles/s4158…
Excited to share that my PhD work is out in @Nature today! We engineered armoured CAR T cells to express therapeutic payloads only at the tumour site, to improve their safety and efficacy for the treatment of solid cancers. 1/14 nature.com/articles/s4158…